| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $988K | +114.3% |
| Cost of Revenue | $852K | +164.1% |
| Gross Profit | $136K | -1.9% |
| R&D Expense | $113K | +189.0% |
| SG&A Expense | $37K | -73.7% |
| Operating Income | -$869K | -52.9% |
| Interest Expense | $619K | -15.6% |
| Pre-tax Income | -$4.9M | -118.1% |
| Net Income | -$4.9M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40K | +18.9% |
| Accounts Receivable | $43K | +2857.7% |
| Current Assets | $82K | +117.0% |
| Total Assets | $680K | -36.3% |
| Current Liabilities | $9.1M | +107.4% |
| Total Liabilities | $9.2M | +82.6% |
| Stockholders' Equity | -$8.5M | -114.7% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$478K | -12.6% |
| Investing Cash Flow | $34K | +105.3% |
| Financing Cash Flow | $450K | -58.2% |
| -118.1% |